In conclusion, cytoplasmic Cx32 exerted nonjunctional effects to protect HCC cells from chemotherapy-induced apoptosis via binding to Src and activating the EGFR signaling pathway in vitro and in vivo. The gene discussed is GJB1; the disease is hepatocellular carcinoma.